P1 ‐064: An independent analysis of 43 758 adverse drug reactions relating to the new hepatitis C direct acting antivirals submitted to the FDA FAERS reporting system between April 2014 and September 2017

Journal of Viral Hepatitis,Volume 25, Issue S2, Page 55-55, June 2018.
Source: Journal of Viral Hepatitis - Category: Infectious Diseases Source Type: research